Ji Oh Mok
Overview
Explore the profile of Ji Oh Mok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho Y, Kim B, Jin S, Jung C, Mok J, Kim S, et al.
Thyroid
. 2024 Dec;
35(1):60-68.
PMID: 39705078
Several meta-analyses have found no association between Graves' disease (GD) and an increased risk of incident diabetes; however, the intricate relationship between thyroid dysfunction and diabetes remains underexplored. In this...
2.
Cho Y, Ahn S, Lee E, Park Y, Choi D, Kim B, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(5):1383-1392.
PMID: 38113188
Context: The decision on diagnostic lobectomy for follicular neoplasms (FN) is challenging. Objective: This meta-analysis investigates whether an appropriate size cutoff exists for recommending surgery for thyroid nodules diagnosed as...
3.
Kim K, Han K, Kim T, Park C, Park J, Kim S, et al.
Diabetes Metab
. 2023 Mar;
49(4):101440.
PMID: 36906135
Aims: This study evaluated the efficacy and safety of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitor, versus dapagliflozin in Korean patients with type 2 diabetes mellitus (T2DM) inadequately controlled with...
4.
Cho Y, Kim B, Shin D, Youn J, Mok J, Kim C, et al.
Brain Commun
. 2022 Feb;
4(1):fcac014.
PMID: 35187486
Two European cohort studies have suggested that Graves' disease is associated with the development of Parkinson's disease, although the results were limited and controversial. We evaluated whether patients with Graves'...
5.
Jun J, Jeong I, Yu J, Kim S, Lee I, Han K, et al.
Diabetes Metab J
. 2019 Jun;
44(1):78-90.
PMID: 31237134
Background: Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a secondary...
6.
Choi D, Jung C, Mok J, Kim C, Kang S, Kim B
Endocrinol Metab (Seoul)
. 2018 Sep;
33(3):387-394.
PMID: 30229578
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are expected to improve the liver function of patients with non-alcoholic fatty liver disease (NAFLD) combined type 2 diabetes mellitus (T2DM) by its characteristic mechanism....
7.
Park J, Park S, Yoon K, Kim S, Ahn K, Lee J, et al.
Diabetes Obes Metab
. 2017 Apr;
19(12):1681-1687.
PMID: 28448688
Aims: To evaluate the efficacy and safety of evogliptin, a newly developed dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes (T2D) inadequately controlled by diet and exercise. Materials And...
8.
Park K, Jung C, Mok J, Kwak J, Lee S
Surg Endosc
. 2015 Dec;
30(9):3797-801.
PMID: 26659230
Background: Total thyroidectomy can be accomplished in one of two ways. The first is an open conventional approach, and the other is an endoscopic unilateral axillobreast approach (UABA). However, the...
9.
Kim K, Kim B, Mok J, Kim C, Kang S, Jung C
Endocrinol Metab (Seoul)
. 2015 Oct;
30(3):318-25.
PMID: 26435134
Background: Thyroid hormones can influence energy metabolism and insulin sensitivity via their interaction with adipocytokines and gut hormones. The aims of this study were to evaluate differences in serum ghrelin...
10.
Park K, Mok J, Chung C, Lee S
Clin Exp Otorhinolaryngol
. 2015 Mar;
8(1):76-80.
PMID: 25729500
Objectives: This study prospectively evaluated postthyroidectomy syndrome (PTS) through objective and subjective voice changes following thyroidectomy of open vs. endoscopic thyroidectomy. Methods: A prospective clinical trial (SCHBC IRB 09 26)...